{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:32:19Z","timestamp":1787243539878,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.neulet.2023.137477","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T22:54:44Z","timestamp":1694645684000},"page":"137477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Effect of U50488, a selective kappa opioid receptor agonist and levetiracetam against lithium-pilocarpine-induced status epilepticus, spontaneous convulsive seizures and related cognitive impairment"],"prefix":"10.1016","volume":"815","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4957-3542","authenticated-orcid":false,"given":"Hemant","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatinder","family":"Katyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogendra","family":"Kumar Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2023.137477_b0005","doi-asserted-by":"crossref","unstructured":"M.Y. Al-Shorbagy, B.M. El Sayeh, D.M. Abdallah. Additional Antiepileptic mechanisms of levetiracetam in lithium-pilocarpine treated rats. Chang AYW, editor. PLoS ONE. 2013 Oct 3;8(10):e76735.","DOI":"10.1371\/journal.pone.0076735"},{"issue":"3","key":"10.1016\/j.neulet.2023.137477_b0010","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0022-3565(24)37305-7","article-title":"Administered and endogenously released kappa opioids decrease pilocarpine-induced seizures and seizure-induced histopathology","volume":"284","author":"Bausch","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1\u20132","key":"10.1016\/j.neulet.2023.137477_b0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0006-8993(99)01189-0","article-title":"Effects of enadoline on the development of pentylenetetrazol kindling, learning performance, and hippocampal morphology","volume":"823","author":"Becker","year":"1999","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.neulet.2023.137477_b0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuropharm.2007.05.001","article-title":"Prophylactic treatment with levetiracetam after status epilepticus: Lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats","volume":"53","author":"Brandt","year":"2007","journal-title":"Neuropharmacology"},{"issue":"5\u20136","key":"10.1016\/j.neulet.2023.137477_b0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.lfs.2011.11.003","article-title":"Positive impact of levetiracetam on emotional learning and memory in naive mice","volume":"90","author":"Celikyurt","year":"2012","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.neulet.2023.137477_b0030","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.physbeh.2007.10.015","article-title":"Neuroprotection and functional recovery conferred by administration of kappa- and delta1-opioid agonists in a rat model of global ischemia","volume":"93","author":"Charron","year":"2008","journal-title":"Physiology & Behavior."},{"key":"10.1016\/j.neulet.2023.137477_b0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0404.2007.00803.x","article-title":"Advances in the pathophysiology of status epilepticus","volume":"115","author":"Chen","year":"2007","journal-title":"Acta Neurologica Scandinavica."},{"issue":"1\u20132","key":"10.1016\/j.neulet.2023.137477_b0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0169-328X(91)90132-H","article-title":"Systemic administration of kainic acid differentially regulates the levels of prodynorphin and proenkephalin mRNA and peptides in the rat hippocampus","volume":"9","author":"Douglass","year":"1991","journal-title":"Mol. Brain Res."},{"issue":"1","key":"10.1016\/j.neulet.2023.137477_b0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-3565(25)39383-3","article-title":"Anticonvulsant and related effects of U-54494A in various seizure tests","volume":"267","author":"Fischer","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.neulet.2023.137477_b0050","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1528-1167.2006.00454.x","article-title":"Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus","volume":"47","author":"Gibbs","year":"2006","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.neulet.2023.137477_b0055","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1528-1157.2002.18101.x","article-title":"Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy","volume":"43","author":"Glien","year":"2002","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.neulet.2023.137477_b0060","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1196\/annals.1316.063","article-title":"\u03b17-type nicotinic acetylcholine receptor and prodynorphin mRNA expression after administration of (\u2212)-nicotine and U-50,488H in \u03b2-amyloid peptide (25\u201335)-treated mice","volume":"1025","author":"Hiramatsu","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.neulet.2023.137477_b0065","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.brainres.2004.10.020","article-title":"Involvement of \u03ba-opioid receptors and \u03c3 receptors in memory function demonstrated using an antisense strategy","volume":"1030","author":"Hiramatsu","year":"2004","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.neulet.2023.137477_b0070","first-page":"357","article-title":"Involvement of serotonergic mechanisms in the inhibitory effect of U-50,488H on glutamate-induced lethality in mice","volume":"75","author":"Kamei","year":"1992","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"issue":"3","key":"10.1016\/j.neulet.2023.137477_b0075","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.neuropharm.2006.10.007","article-title":"Pharmacological and genetic manipulation of kappa opioid receptors: effects on cocaine- and pentylenetetrazol-induced convulsions and seizure kindling","volume":"52","author":"Kaminski","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2023.137477_b0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yebeh.2015.04.065","article-title":"Incidence and mortality of super-refractory status epilepticus in adults","volume":"49","author":"Kantanen","year":"2015","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.neulet.2023.137477_b0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.eplepsyres.2017.03.009","article-title":"Long-term outcome of refractory status epilepticus in adults: a retrospective population-based study","volume":"133","author":"Kantanen","year":"2017","journal-title":"Epilepsy Res."},{"issue":"2\u20133","key":"10.1016\/j.neulet.2023.137477_b0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(98)00410-5","article-title":"Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy","volume":"353","author":"Klitgaard","year":"1998","journal-title":"Eur. J. Pharmacol."},{"issue":"135","key":"10.1016\/j.neulet.2023.137477_b0095","article-title":"Effect of morphine administration after status epilepticus on epileptogenesis in rats","volume":"1","author":"Kumar","year":"2022","journal-title":"Epilepsy & Behavior."},{"issue":"5","key":"10.1016\/j.neulet.2023.137477_b0100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1006\/ebeh.2000.0098","article-title":"Absence of Negative Impact of Levetiracetam on Cognitive Function and Memory in Normal and Amygdala-Kindled Rats","volume":"1","author":"Lamberty","year":"2000","journal-title":"Epilepsy & Behavior."},{"issue":"2","key":"10.1016\/j.neulet.2023.137477_b0105","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0006-8993(89)91196-7","article-title":"The interaction between kappa-opioid agonist, U-50, 488H, and kainic acid: behavioral and histological assessments","volume":"482","author":"Lason","year":"1989","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neulet.2023.137477_b0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0091-3057(03)00218-1","article-title":"Studies on the anticonvulsant effect of U50488H on maximal electroshock seizure in mice","volume":"76","author":"Manocha","year":"2003","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"1","key":"10.1016\/j.neulet.2023.137477_b0120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0306-4522(98)00320-0","article-title":"Opioid peptide pharmacology and immunocytochemistry in an animal model of self-sustaining status epilepticus","volume":"89","author":"Mazarati","year":"1999","journal-title":"Neuroscience"},{"issue":"2\u20133","key":"10.1016\/j.neulet.2023.137477_b0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.eplepsyres.2004.02.002","article-title":"Anticonvulsant effects of levetiracetam and levetiracetam\u2013diazepam combinations in experimental status epilepticus","volume":"58","author":"Mazarati","year":"2004","journal-title":"Epilepsy Res."},{"issue":"Suppl 8","key":"10.1016\/j.neulet.2023.137477_b0130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1528-1167.2007.01362.x","article-title":"The risk of epilepsy after status epilepticus in children and adults","volume":"48","author":"Meierkord","year":"2007","journal-title":"Epilepsia"},{"issue":"2\u20133","key":"10.1016\/j.neulet.2023.137477_b0135","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.eplepsyres.2010.01.011","article-title":"Antiepileptogenic and anticonvulsive actions of levetiracetam in a pentylenetetrazole kindling model","volume":"89","author":"Ohno","year":"2010","journal-title":"Epilepsy Res."},{"issue":"3","key":"10.1016\/j.neulet.2023.137477_b0140","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neulet.2005.05.048","article-title":"Evaluation of levetiracetam effects on pilocarpine-induced seizures: cholinergic muscarinic system involvement","volume":"385","author":"Oliveira","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2023.137477_b0145","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0024-3205(83)90573-8","article-title":"The effect of various opiate receptor agonists on the seizure threshold in the rat. Is dynorphin an endogenous anticonvulsant?","volume":"33","author":"Przew\u0142ocka","year":"1983","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.neulet.2023.137477_b0150","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0924-977X(94)90302-6","article-title":"Kappa opioid receptor agonists inhibit the pilocarpine-induced seizures and toxicity in the mouse","volume":"4","author":"Przew\u0142ocka","year":"1994","journal-title":"European Neuropsychopharmacology."},{"issue":"3","key":"10.1016\/j.neulet.2023.137477_b0155","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1186\/cc13883","article-title":"Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study","volume":"18","author":"Pugin","year":"2014","journal-title":"Critical Care."},{"issue":"4","key":"10.1016\/j.neulet.2023.137477_b0160","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hipo.10078","article-title":"Opioid peptide release in the rat hippocampus after kainic acid-induced status epilepticus","volume":"13","author":"Rocha","year":"2003","journal-title":"Hippocampus"},{"key":"10.1016\/j.neulet.2023.137477_b0165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.yebeh.2017.11.019","article-title":"Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model","volume":"79","author":"Sanon","year":"2018","journal-title":"Epilepsy & Behavior."},{"key":"10.1016\/j.neulet.2023.137477_b0170","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yebeh.2015.04.059","article-title":"Prognosis of status epilepticus (SE): Relationship between SE duration and subsequent development of epilepsy","volume":"49","author":"Santamarina","year":"2015","journal-title":"Epilepsy & Behavior."},{"key":"10.1016\/j.neulet.2023.137477_b0175","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.brainres.2010.06.061","article-title":"Levetiracetam suppresses development of spontaneous EEG seizures and aberrant neurogenesis following kainate-induced status epilepticus","volume":"1352","author":"Sugaya","year":"2010","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.neulet.2023.137477_b0180","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s11596-015-1482-6","article-title":"Prodynorphin gene promoter polymorphism and temporal lobe epilepsy: a meta-analysis","volume":"35","author":"Zhang","year":"2015","journal-title":"Journal of Huazhong University of Science and Technology [Medical Sciences]."},{"issue":"4\u20135","key":"10.1016\/j.neulet.2023.137477_b0185","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.neuropharm.2009.12.007","article-title":"Intravenous levetiracetam in the rat pilocarpine-induced status epilepticus model: Behavioral, physiological and histological studies","volume":"58","author":"Zheng","year":"2010","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neulet.2023.137477_b0190","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.eplepsyres.2006.08.007","article-title":"Effect of levetiracetam on visual-spatial memory following status epilepticus","volume":"73","author":"Zhou","year":"2007","journal-title":"Epilepsy Res."},{"issue":"7","key":"10.1016\/j.neulet.2023.137477_b0195","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1528-1167.2008.01594.x","article-title":"Anticonvulsive and antiepileptogenic effects of levetiracetam in the audiogenic kindling model","volume":"49","author":"Vinogradova","year":"2008","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.neulet.2023.137477_b0110","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0306-4522(92)90320-2","article-title":"The prodynorphin system in the rat hippocampus is differentially influenced by kainic acid and pentetrazole","volume":"51","author":"Laso\u0144","year":"1992","journal-title":"Neuroscience"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394023004366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394023004366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:49:02Z","timestamp":1759625342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394023004366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":39,"alternative-id":["S0304394023004366"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2023.137477","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of U50488, a selective kappa opioid receptor agonist and levetiracetam against lithium-pilocarpine-induced status epilepticus, spontaneous convulsive seizures and related cognitive impairment","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2023.137477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"137477"}}